XM n’offre pas ses services aux résidents des États-Unis d’Amérique.
L
L

Loreal


Actualités

Jefferies ups L'Oreal to 'hold' as market growth normalisation is now priced in

REFILE-BUZZ-Jefferies ups L'Oreal to 'hold' as market growth normalisation is now priced in Removes extraneous words in headline, updates share move ** Jefferies raises L'Oreal OREP.PA to "hold" from "underperform," saying slowing beauty market growth is increasingly priced in to the French cosmetics company's shares ** "With less risk to short-ter
L

Crest Nicholson, JDE Peet's, L'Oreal

EUROPE RESEARCH ROUNDUP-Crest Nicholson, JDE Peet's, L'Oreal Aug 14 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Crest Nicholson Holdings, JDE Peet's and L'Oreal, on Wednesday. HIGHLIGHTS * A.P. Moller-Maersk MAERSKb.CO : Deutsche Bank cuts PT to DKK 9217 from DKK 9283 * British American Tobacco Plc BATS.L : Barclays raises target price to 3100p from 2650p * Crest Nicholson Holdings Plc CRST.L : Peel Hunt cuts to hold from add *
A
B
C
C
D
E
E
E
H
J
L
N
R
S
S
T
U
U
U
A
E
F
P

Douglas upbeat on Europe's premium beauty market despite luxury slowdown

UPDATE 3-Douglas upbeat on Europe's premium beauty market despite luxury slowdown Adds comments from conference call in paragraph 2, 4, 8, cosmetics makers' results in paragraph 3 By Eva Orsolya Papp and Andrey Sychev GDANSK, Aug 14 (Reuters) - Douglas DOU1.DE is betting on the European premium beauty market to keep growing despite a wider luxury market slowdown , the German perfume and cosmetics retailer said after it posted higher quarterly core earnings on Wednesday.
B
L

1 drugs and approvals to underpin Galderma, says JPM

BUZZ-GLP-1 drugs and approvals to underpin Galderma, says JPM ** Shares of Galderma GALD.S rise around 3% after J.P.Morgan initiates the Swiss firm with "overweight", saying it offers an attractive play on the fast growing skin-care market and strong EBITDA margin expansion ** Broker sees the company delivering sustained double-digit revenue growth
J
L

Beiersdorf misses profit forecast, says slow China hit luxury brand sales

UPDATE 3-Beiersdorf misses profit forecast, says slow China hit luxury brand sales Updates share move, adds Q2 growth for consumer business in paragraph 6, management comments paragraphs 11-12 By Eva Orsolya Papp and Marleen Kaesebier Aug 7 (Reuters) - Nivea maker Beiersdorf BEIG.DE missed expectations for half-year operating profit on Wednesday and said the luxury market slowdown in China had hit the sales of its La Prairie brand.
B
L
G

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds: Schaeffler, T&L Sugars, TotalEnergies Aug 6 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Tuesday: ** German machine and car parts maker Schaeffler SHA_p.DE is not interested in a takeover of Continental's automotive division, CEO Klaus Rosenfeld told the Handelsblatt newspaper, adding the company had "completely other priorities".
L

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Aug 6 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 0930 GMT on Tuesday: ** Japan's largest city gas provider Tokyo Gas 9531.T said it will buy a 21.2% stake in the WindFloat Atlantic operational floating offshore wind power project in Portugal to gain experience in operation and maintenance.
L

Wall Street Journal - Aug 6

PRESS DIGEST -Wall Street Journal - Aug 6 Aug 6 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. - A federal judge ruled that Google GOOGL.O engaged in illegal practices to preserve its search engine monopoly, delivering a major antitrust victory to the Justice Department in its effort to rein in Silicon Valley technology giants.
G
L

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds: Thoughtworks, Tenet Healthcare, Mallinckrodt, Quantum Capital Group, Credit Agricole Updates: L'Oreal Aug 5 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Monday: ** Thoughtworks TWKS.O agreed to be taken private by Apax Partners in a deal worth about $1.75 billion, the technology consultancy firm said, nearly three years after its stock market debut.
C
G
K
L
O
S
W

L’Oréal’s tardy skin care facelift may backfire

BREAKINGVIEWS-L’Oréal’s tardy skin care facelift may backfire The author is a Reuters Breakingviews columnist. The opinions expressed are her own. Refiles to fix typo in third paragraph. By Yawen Chen LONDON, Aug 5 (Reuters Breakingviews) - L’Oréal OREP.PA seems to be having second thoughts. Ten years after selling its stake in medical skin specialist Galderma GALD.S , the French cosmetics giant said on Monday it was buying a 10% stake in the $19 billion fast-growing Swiss-listed firm.
L

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Aug 5 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 0930 GMT on Monday: ** Dubai's Sidara said it was walking away from its plan to buy UK's John Wood Group WG.L , citing rising geopolitical risks and uncertainty in the financial market, prompting the British engineering group's shares to plunge 40%.
K
L
O
S
W

STOXX 600 hits six-month low in global rout on US recession fears

UPDATE 2-STOXX 600 hits six-month low in global rout on US recession fears For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Volatility index hits highest since March 2022 Major European exchanges touch multi-month lows Euro zone business growth at a standstill, survey shows Galderma up after L'Oreal says it will buy 10% stake STOXX 600 closes down 2.2% Updated at 1600 GMT By Ankika Biswas and Pranav Kashyap Aug 5 (Reuters) - The main Euro
A
I
L
O
J
E
F
S
U
G

Galderma on track for best day ever as L'Oreal to take stake

BUZZ-Galderma on track for best day ever as L'Oreal to take stake ** Shares in Galderma GALD.S jump around 7% after L'Oreal OREP.PA said it will acquire a 10% stake in the Swiss skin care firm for an undisclosed premium ** Jefferies analysts say in a note they assume it is "a way to get closer to Galderma with a view of higher ownership/ control ov
L

L'Oreal to buy 10% stake in Swiss skincare firm Galderma

UPDATE 4-L'Oreal to buy 10% stake in Swiss skincare firm Galderma Adds comments from Galderma CEO after analyst call, paragraphs 12-13 By Dave Graham and Dominique Patton ZURICH/PARIS, Aug 5 (Reuters) - L'Oreal OREP.PA will acquire a 10% stake in Swiss skin care firm Galderma GALD.S from a group of major shareholders, the two companies said on Monday, as the French firm seeks a cut of the profits from the booming injectable cosmetics market.
L
N

L'Oreal to acquire 10% stake in Swiss skin care firm Galderma

L'Oreal to acquire 10% stake in Swiss skin care firm Galderma ZURICH, Aug 5 (Reuters) - French cosmetics company L'Oreal OREP.PA is to acquire a 10% stake in Swiss skin care firm Galderma GALD.S , the two companies said on Monday. "L'Oreal today announces the acquisition of a 10% stake in Galderma Group AG from Sunshine SwissCo AG (a consortium led by EQT), Abu Dhabi Investment Authority (ADIA), Auba Investment Pte.
L

L'Oreal acquires 10% stake in dermatology company Galderma

CORRECTED-L'Oreal acquires 10% stake in dermatology company Galderma Corrects to show stake is 10%, not 105, in headline Aug 5 (Reuters) - L'Oreal OREP.PA has announced the acquisition of a 10% stake in dermatology solutions provider Galderma Group GALD.S , the French cosmetics giant said in a statement on Monday. The company acquired the shares from Sunshine SwissCo AG, Abu Dhabi Investment Authority (ADIA), and Auba Investment Pte Ltd for an undisclosed sum and the transaction will be funded w
L

L’Oréal Groupe Acquires A 10% Stake In Galderma

BRIEF-L’Oréal Groupe Acquires A 10% Stake In Galderma Aug 5 (Reuters) - L'Oreal SA OREP.PA : L’ORÉAL GROUPE ACQUIRES A 10% STAKE IN GALDERMA, THE PURE-PLAY DERMATOLOGY LEADER AND ONE OF THE WORLD’S LARGEST PLAYERS IN INJECTABLE AESTHETICS TRANSACTION WILL BE FUNDED WITH L'ORÉAL'S AVAILABLE CASH AND CREDIT LINES, AND CLOSING IS EXPECTED TO
L

China's stuttering recovery darkens global corporate growth outlook

ANALYSIS-China's stuttering recovery darkens global corporate growth outlook By Medha Singh Aug 2 (Reuters) - Global burger chains to car manufacturers are increasingly feeling the pinch from a faltering recovery in the world's No. 2 economy , China, and are strapping in for a bumpy ride ahead. A protracted downturn in the property market and high levels of job insecurity have knocked the wind out of a fragile recovery in China, a global trading powerhouse, and the effects of its slowdown can be
A
B
B
B
H
K
L
L
M
P
Q
S
T
T

L'Oreal CEO, investors shrug off China weakness

UPDATE 2-L'Oreal CEO, investors shrug off China weakness Adds comment from analyst in paragraphs 4 and 10, further comment from CEO By Dominique Patton PARIS, July 31 (Reuters) - The Chinese beauty market will be slightly negative in the second half of the year, L'Oreal OREP.PA CEO Nicolas Hieronimus said on Wednesday, adding that the French company was not dependent on the market's growth despite undershooting quarterly sales expectations.
L

L'Oreal CEO expects 'slightly negative' H2 growth in China

L'Oreal CEO expects 'slightly negative' H2 growth in China PARIS, July 31 (Reuters) - The Chinese beauty market will stay "slightly negative" in the second half, L'Oreal OREP.PA CEO Nicolas Hieronimus said on Wednesday, after entering negative growth from the second quarter. The company remains "very ambitious" on China in the mid-term, but is not seeing any improvement in consumer confidence currently, he said on a call with analysts.
L



Conditions

Actifs populaires

Avertissement : Les entités de XM Group proposent à notre plateforme de trading en ligne un service d'exécution uniquement, autorisant une personne à consulter et/ou à utiliser le contenu disponible sur ou via le site internet, qui n'a pas pour but de modifier ou d'élargir cette situation. De tels accès et utilisation sont toujours soumis aux : (i) Conditions générales ; (ii) Avertissements sur les risques et (iii) Avertissement complet. Un tel contenu n'est par conséquent fourni que pour information générale. En particulier, sachez que les contenus de notre plateforme de trading en ligne ne sont ni une sollicitation ni une offre de participation à toute transaction sur les marchés financiers. Le trading sur les marchés financiers implique un niveau significatif de risques pour votre capital.

Tout le matériel publié dans notre Centre de trading en ligne est destiné à des fins de formation / d'information uniquement et ne contient pas – et ne doit pas être considéré comme contenant – des conseils et recommandations en matière de finance, de fiscalité des investissements ou de trading, ou un enregistrement de nos prix de trading ou une offre, une sollicitation, une transaction à propos de tout instrument financier ou bien des promotions financières non sollicitées à votre égard.

Tout contenu tiers, de même que le contenu préparé par XM, tels que les opinions, actualités, études, analyses, prix, autres informations ou liens vers des sites tiers contenus sur ce site internet sont fournis "tels quels", comme commentaires généraux sur le marché et ne constituent pas des conseils en investissement. Dans la mesure où tout contenu est considéré comme de la recherche en investissement, vous devez noter et accepter que le contenu n'a pas été conçu ni préparé conformément aux exigences légales visant à promouvoir l'indépendance de la recherche en investissement et, en tant que tel, il serait considéré comme une communication marketing selon les lois et réglementations applicables. Veuillez vous assurer que vous avez lu et compris notre Avis sur la recherche en investissement non indépendante et notre avertissement sur les risques concernant les informations susdites, qui peuvent consultés ici.

Avertissement sur les risques : votre capital est à risque. Les produits à effet de levier ne sont pas recommandés pour tous. Veuillez consulter notre Divulgation des risques